Standard BioTools Inc. (NasdaqGS: LAB)
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of SomaLogic, Inc. (NasdaqGM: SLGC) to Standard BioTools Inc. (“the Company”) (NasdaqGS: LAB). Under the terms of the proposed transaction, upon closing of the proposed transaction, Standard BioTools shareholders will own approximately 43% of the combined company. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.
If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (firstname.lastname@example.org) toll free at any time at 855-768-1857, or fill out the form on this page.